Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Active Biotech, AIM Immunotech, ALK-Abelló, Bellicum, Bridge, Coda, Hoth, Kymera, Merck, Morphosys, Oncocyte, Spero, Tela, X-Chem.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alydia Health, Carmat, Dysis Medical, Globus Medical, Insight Genetics, Isoray, Mim Software, Ngmedical, Oncocyte, Profound Medical, Pya Analytics, Staar Surgical, Verana Health.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Aivita, Emtora, Genprex, Menlo, Minerva, Phasebio.

Biopharmas raising money in public or private financings, including: Arcutis, Beam, DBV, Ikarovec, Integra, Kezar, Phio, Rapt, Revive, Ziopharm.

Quarterly snapshots from biopharma companies with marketed products, including: Neurocrine.

New hires and promotions in the biopharma industry, including: Abalos, Aerami, Amylyx, Arrakis, Atara, Epirium, Generex, Khondrion, Magenta.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: CHF Solutions, Eyeyon Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Accuray, Cytosorbents, Htg Molecular Diagnostics, Tela Bio.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Advaccine, Anticancer, Asahi Kasei, Aspen, Avacta, BGI, Biolexis, Celularity, Clover, Curetis, Curevac, Daewoong, Duke-National University, Horizon, Inovio, Novartis, Outlook, Oxford Gene Technology, Sandoz, Sorrento, Sysmex, Takeda, Veloxis, Wuhan Institute of Virology, Wuxi Biologics.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Bio-Thera Solutions, CSPC, Exopharm, Exscientia, Otsuka, Rani, Teva, Verastem